eCommons@AKU
Department of Surgery

Department of Surgery

9-1-2021

Endoleaks: Current concepts and treatments - A narrative review
Zia Ur Rehman

Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_surg
Part of the Cardiology Commons, Cardiovascular Diseases Commons, and the Surgery Commons

2224

NARRATIVE REVIEW
Endoleaks: Current concepts and treatments - A Narrative Review
Zia Ur Rehman

Abstract
Endoleaks are the most common complications following
endovascular aneurysm repair. Depending upon their
origin, there are five types of endoleaks, types I-V, which
can also be classified as direct and indirect endoleaks.
Direct endoleaks (type I and III) have higher risk of
aneurysm rupture due to rapid sac expansion, and require
immediate correction. Indirect endoleaks ( type II, IV and
V) have a relatively benign course compared to direct
endoleaks. Most of them resolve with time and very few
need interventions upon sac enlargement. Type V
endotension is a special situation where there is sac
enlargement despite no demonstrable endoleak. Proper
planning and appropriate selection of stent-graft can
prevent most of these endoleaks. With improvement in
stent-graft technology, the incidence of endoleaks has
been reduced. The current narrative review was planned
to describe the pathophysiology, risk factors and
treatment options for each type of endoleak.
Keywords: Endovascular, Endoleak, Embolisation.
DOI: https://doi.org/10.47391/JPMA.03-345

Introduction
Endovascular aortic aneurysm repair (EVAR) has become
the preferred treatment modality for treating aortic
aneurysms. Endoleaks are the most common
complication following EVAR, and are regarded as
treatment failure. They are traditionally divided into five
types based on their origin (Table). Type I, or
implantation, endoleaks occur at the stent-graft landing
sites. These are due to inadequate apposition of stentgraft with arterial wall. Type II, or backflow, endoleaks are
due to retrograde filling of the aneurysm cavity from one
of the branch vessels. Type III, or junction, endoleaks are
due to extravasation of blood at stent-graft component
junction points or due to graft fabric tear. Type IV, or
porosity, endoleaks are due to porosity of the stent-graft.
Type V is a special situation where there is sac
enlargement despite no demonstrable endoleak. The
limitation of this classification is that it does not shed light
on any urgency of treatment. A more practical way to
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Table: Classification of endoleaks.
Type of Endoleak

Description

Type I

Failure to achieve adequate seal
Ia- Proximal Landing site
Ib- Distal landing site
Ic- Common Iliac artery
Type II
Backflow of blood from aortic collaterals into the aneurysm sac
Early — Occurring within 30 days of Endovascular aortic
aneurysm repair (EVAR)
Late — Occurring after 1 year of EVAR
Persistant- Present for more than 6 months after EVAR
Type III
Endoleak secondary to structural failure of endograft
IIIa — Component separation
IIIb — Stent fabric disturbance
Type IV
Related to graft fabric porosity
Type V (Endotension) Continued high intra-sac pressure following EVAR without
evidence of aneurysmal sac perfusion

classify endoleaks is to divide them into 'direct' and
'indirect' endoleaks. Direct endoleaks types I and III
transmit direct systemic pressure into the aneurysmal
cavity. Due to this direct pressure, there is always risk of
rapid aneurysm enlargement and rupture. Therefore, they
need immediate repair. Indirect endoleaks increase sac
pressure by an indirect way either through small branches
or through the graft wall. The sac can increase in size, but
at a slower rate than direct endoleaks. They have a
relatively benign course as most resolve with time and
very few require interventions (Figure-1).

Best way to detect endoleaks
Completion angiogram can detect early types I and III
endoleaks. Delayed images can show type II endoleaks.
Contrast-enhanced computed tomography (CT) is the
gold standard for the detection of endoleaks on
subsequent visits. A complete CT study requires a triplephase CT angiography (CTA), also called an angiogram.
Arterial phase images show types I and III endoleaks,
images delayed by 2-3 minutes show type II endoleaks,
and non-contrast-enhanced images show mural calcium,
which might otherwise be misidentified as contrastenhanced blood, or endoleak.
Duplex ultrasound can also detect an endoleak. It is
economical, free of radiation and contrast. Besides
detecting the endoleak, it can also provide information on
different types of flow and directions in these endoleaks.1
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CTA: Computed tomography angiography.

Figure-1: Flow-chart showing timing and approach to different types of endoleaks.

Its limitations are that it is operator-dependent.

Type I implantation endoleaks
Type I endoleaks are due to poor apposition of stent-graft
to the arterial wall and occur either at proximal (type Ia) or
distal (type Ib) sites. They normally occur when an
unfavourable anatomy, such as hostile aortic neck or
ectatic iliac artery, is being treated. The persistent flow
between the graft and arterial wall increases pressure
within the aneurysm. Most type I endoleaks occur 'early'.
Due to graft migration or late neck dilation, some patients
can develop 'late' type 1 endoleaks.

Early type 1 endoleaks
Short, angulated, heavily calcified infrarenal neck, and
neck with thombus are the risk factors for early type Ia
endoleaks. Currently permitted infrarenal stent-grafts
mandate minimum neck length of 10-15mm to achieve
an adequate seal. Depending on the accuracy of stentgraft placement, a significant length of infrarenal
coverage can be lost and this may jeopardise the
endograft seal.

Late type I endoleaks
Most cases of late type I endoleaks are those in which
stent-graft had been placed outside of instructions for use
(IFU) criteria.2 The presence of hostile neck anatomy
J Pak Med Assoc

affects long-term outcome.3 Wide and angulated necks
and dilated iliac landing zones have a higher risk of
producing late type I endoleaks.4 It is essential to position
the stent-graft in healthy landing zones at both proximal
and distal ends to achieve a good long-term outcome. It
may mean outspreading the repair across the visceral
arterial segment and/or prolonging the repair beyond the
iliac bifurcation, if needed.

Type I endoleak management
There are some adjuncts that can be used to treat type I
endoleaks (Figure-2).
a. Intraoperative angioplasty
The first step to treat a proximal type I endoleak is a
balloon angioplasty with a semi-compliant balloon, like
Coda (Cook) or Reliant (Medtronic), which passes over a
stiff wire, such as Lunderqvist (Cook) or Amplants (Cordis).
Percutaneous transluminal angioplasty (PTA) will
sometimes align the graft better in an angled neck and/or
decrease graft infolding and gutters that may arise with
graft oversizing. If it is unable to correct type I endoleak,
the aortic cuff can be considered to seal this.
b. Cuff placement
The practice for an endograft cuff employment is almost
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balloon is then inflated steadily at a slow pace. Inflating or
deflating the balloon is done until the stent is fully
deployed. A slight cranial pressure is also deployed to
mitigate the 'wind sock' effect. When the proximal end of
the stent is deployed against the endograft, an assistant is
asked to retract the 16F sheath to fully uncover the stent.
The balloon can be deflated and repositioned to allow for
further moulding of the stent that is sometime necessary.
Comparable results have been noted between the
patients undergoing bare metal stent versus those having
extension cuff repair.5
d. EndoAnchors

Figure-2: Flow-chart showing different options for treating type 1 endoleaks.

similar to the initial endograft placement. Initial type Ia
endoleak treatment is predicted on the position of the
endograft to the lowest renal artery. If the distance is
<3mm, the seal zone should undergo angioplasty with a
compliant moulding balloon. If the distance is >5mm, the
initial placement of an aortic cuff is followed by compliant
balloon angioplasty.
If type I endoleak is due to insufficient neck length or
utilisation of such a neck, proximal cuff extension might
not be an appropriate option. The problem can be better
solved by Palmaz stent placement.
c. Palmaz stent placement
Various techniques have been described for Palmaz stent
placement. One of them is described here:
The first step involves placing a 16F 45cm sheath from the
groin with it tip positioned above the renal arteries. The
giant Palmaz stent (40-14) is then crimped onto a Coda
balloon. By gently dilating the stent with a 14-16F dilator,
it is easier to fit it onto the balloon. The mounted stent is
passed through sheath while being careful when pushing
it through the valve so it does not slip off the balloon. The
stent is positioned partially across the renal arteries. Since
the nominal size of the stent is 14mm, it will foreshorten
significantly when taken up to the size of an endograft.
Exactly how much it will shorten is sometimes difficult to
determine precisely. The 16F sheath is retracted so that it
may cover about 1/3 of the distal end of the stent. The

The results of Phase I multicentre trial (STAPLE 1) of the
Aptus endovascular repair system showed the usefulness
of EndoAnchors in EVAR to aid proximal fixation and
sealing.6 A study also showed effectiveness of
EndoAnchors as an adjunct in the treatment of infrarenal
abdominal aortic aneurysm (AAA) with short neck, and
pararenal AAA.7 It demonstrated sealing of type 1a
endoleaks in that case series. When selecting
EndoAnchors, cost implications of these have to be
considered. The cost of EndoAnchors can be as high as
the actual EVAR stent-graft.
e. Embolisation
Embolisation in the perigraft space can seal the endoleak
in 'selected' cases. This option has been shown to be
effective by using various combinations of coils and
embolics.8-10 The commonly used agents are N-butyl
cyano acrylate (NBCA) (Trufill, Cordis, Miami, FL) and Onyx
(Plymouth, MN).
f. Other options
If endovascular manoeuvres fail to improve the seal,
conventional open surgical repair, banding the neck with
soft nylon umbilical tape or a segment of Dacron graft
material, fenestrated endovascular aortic aneurysm repair
(FEVAR) or leaving the endoleak untreated are some of
the options.

Treatment of type Ib endoleak
Ectatic common iliac arteries up to 2cm in diameter are
suitable landing zones for the iliac limb of an aortic
endograft. However, common iliac arteries >2cm
generally necessitate extension of the endograft to the
external iliac artery. When extending to the external iliac
artery, one should be particularly mindful of oversizing,
which can predispose to limb thrombosis or a type Ib
endoleak. There is frequently significant iliac tortuosity in
these cases, which makes accurate length measurements
difficult. When in doubt, a longer limb length should be
Vol. 71, No. 9, September 2021
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chosen for external iliac extension. The internal iliac artery
should be embolised prior to extending the limb into the
external iliac artery.

Type II endoleaks
Type II endoleaks are due to retrograde filling of the
aneurysmal sac from either lumbar, inferior mesenteric,
middle sacral, or aberrant renal arteries. These are the
most common types of endoleaks with surveillance CT
scans showing in 10-20% cases. When managing a
patient with type II endoleaks, questions that come to
mind are: what is the natural course of these
endoleaks?; Which patients are more at risk of
developing type II endoleaks?; What can be the
strategies to reduce incidences of these endoleaks?;
Which of the patients with type II endoleaks need
intervention?; What is the best method to deal with
'persistant type II endoleak?
a. Natural course of type 2 endoleaks
Compared to direct endoleaks, type II endoleaks are
relatively benign.11 As many as 80% of type 2 endoleaks
resolve spontaneously within 6 months of the stent-graft
implantation.12 Those that persist are unlikely to cause
aneurysm pressurisation, dilatation or rupture.13 There is
about 1% of aneurysm rupture reported at 2 years in such
cases.14
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e. Treatment of type 2 endoleaks
Embolisation and occlusion of the feeding arteries is the
aim whilst treating patients with type II endoleaks.
Embolisation can be done by either transarterial or
translumbar route. The sac can be thrombosed by

Figure-3: Flow-chart showing options for treating type 2 endoleaks.

injecting various chemicals (Figure-3).
1. Transarterial embolisation
Embolisation of the branches may be performed
through a super-selective catheterisation or a translumbar approach. Transarterial embolisation is more
likely to succeed when the endoleak cavity is fed
through a patent inferior mesenteric artery. It is usually
possible to pass a microcatheter through the middle
colic branch of the superior mesenteric artery, around
the colonic arcade, and through the left colic artery to
the inferior mesenteric artery. The reported success rate
is 71.4%.19

b. Risk factors for type II endoleaks
2. Translumbar embolisation
Patients with patent inferior mesenteric artery (IMA) and
lumbar arteries (LA) on the pre-operative CTA are more at
risk of developing type 2 endoleaks than patients with
occluded IMA and LA. Out of the patent arteries, patients
with IMA >3mm and lumbar arteries >2mm are more at
risk of developing type 2 endoleaks.15
It is also important to look for the type of aneurysm.
Patients with aorto-iliac type aneurysms are more at risk
of developing this endoleak than patients with saccular
type aneurysms.
c. Prevention of type II endoleaks
Patients with IMA >3mm and LA >2mm can benefit from
prophylactic embolisation which has been shown to be
effective in reducing the incidence of endoleaks.16
d. Indication for intervention for type II endoleaks
Most type II endoleaks resolve with time. Persistence of
endoleak itself is not an indication for intervention.
Indication is warranted in patients where there is
aneurysmal sac enlargement >5 mm.17,18
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If transarterial access fails or is not possible, translumbar
access is the alternative.20 Selective catheterisation is
performed with coaxial microcatheter systems through
which mechanical, liquid, or combined embolic agents
can be delivered.7,21,22 The average success rate after
translumbar embolisation is 81% (range: 67-100%).23 The
target of embolisation should be the nidus and the feeder
branches of the endoleak.
3. Promotion of thrombus formation
Aneurysm is lined by thrombus. Promotion of thrombus
formation inside the aneurysmal sac is considered
another possible method of preventing type 2 endoleak.
A study reported coil embolisation, gelform and fibrin
glue as useful adjuncts in promoting aneurysmal sac
thrombosis.24
f. Treatment for persistent type II endoleaks
If the endoleak persists and the sac continues to grow
after 'technically' successful embolisations, or when
embolisation is impossible, more invasive approach is
required.
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Laparoscopic ligation of the feeding lumbar, IMA and
other side branches are options.25 Laparotomy and
suturing of the side branch ostia within the aneurysmal
sac or conversion to open can be offered in extreme cases.

Type III endoleaks
Type III endoleaks are either due to disconnection of
stent-graft components or due to fabric tear. These
endoleaks are typically treated by the placement of
additional stent-graft.
Component overlap between stent-graft limbs as well as
between main stent-graft components can readily be
seen on plain X-ray films of the abdomen. Often, at times,
radio-opaque markers on the device or the skeletal
components themselves serve as good landmarks for
comparison. Changes in overall stent-graft configuration,
like increased limb or body angulations, often give a
direct hint that the prosthesis is moving, thus increasing
the risk of disconnection and endoleaks.
CT can also be used, but it is more difficult to detect small
configurational changes and minor graft dislocation. To
do this, reconstructions that highlight only the stent-graft
metal components must be used. With modern threedimensional (3D) workstations, this can be achieved
partially or fully automatically. The radiation dose is
manifold higher with CT and this should be taken into
consideration. CTA is of course very useful for identifying
and analysaing the endoleak itself.
Both in the peri- and post-operative periods, type III
endoleaks are mostly treated by the placement of new
stent-graft components in the so-called "relining''. This is
often quite straightforward as long as total separation has
not occurred. In very challenging tortuous anatomy, it is
sometime difficult to place additional main components.
In such a setting, balloon expandable stent can be used to
reinforce junctions if complete dislocation has not
occurred.

Endoleaks: Current concepts and treatments

open conversion and explantation is advised which is a
major undertaking. The other is a hybrid approach using
both endovascular and laparoscopic options. It may
include laparoscopic clipping of all lumbar arteries,
placement of a Dacron cuff to seal the neck
laparoscopically, use of EndoAnchors to help fixate the
stent-graft, and introducing a thrombotic agent into the
aneurysmal sac to occlude the cavity.

Conclusion
Endoleaks are the most common complications following
EVAR. Proper planning and appropriate selection of stentgraft can prevent most of these endoleaks. With
improvement in stent-graft technology, the incidence of
endoleaks has been reduced.
Disclaimer: None.
Conflict of Interest: None.
Source of Funding: None.

References
1.

2.

3.

4.

5.

6.

Type IV endoleaks
Type IV endoleak is due to porosity of stent-graft fabric
without any signs of tear or erosion. This usually happens
when the graft material is highly porous. Mostly it resolves
by itself. This endoleak is typically observed without any
intervention. With improved quality of graft fabric, the
incidence of these endoleaks has markedly decreased.

7.

8.

9.

Type V endotension endoleaks
Endotension is when there is no demonstrable endoleak,
but there is sac expansion. Its exact aetiology is not
known. The treatment is exclusion of any endoleak and
close surveillance. In case of expanding aneurysm, the

10.

Maximus S, Skelly C, Milner R. Velocities of type II endoleaks on
Doppler ultrasonography predict outcome. J Vasc Surg. 2020;
71:1719‐25.
AbuRahma AF, Yacoub M, Mousa AY, Abu-Halima S, Hass SM, Kazil
J, et al. Aortic Neck Anatomic Features and Predictors of
Outcomes in Endovascular Repair of Abdominal Aortic Aneurysms
Following vs Not Following Instructions for Use. J Am Coll Surg.
2016; 222:579‐89.
Oliveira NFG, Gonçalves FB, Hoeks SE, Van Rijn JM, Ultee K, Pinto
JP, et al. Long-term outcomes of standard endovascular aneurysm
repair in patients with severe neck angulation. J Vasc Surg. 2018;
68:1725‐35.
AbuRahma AF, DerDerian T, AbuRahma ZT, Hass SM, Yacoub M,
Dean LS, et al. Comparative study of clinical outcome of
endovascular aortic aneurysms repair in large diameter aortic
necks (>31 mm) versus smaller necks. J Vasc Surg. 2018;
68:1345‐53.
Rajani RR, Arthurs ZM, Srivastava SD, Lyden SP, Clair DG, Eagleton
MJ, et al. repairing immediate proximal endoleaks during
abdominal aortic aneurysm repair. J Vasc Surg. 2011; 53:1174-7.
Deaton DH, Mehta M, Kasirajan K, Chaikof E, Farber M, Glickman
MH, et al. The phase I multicenter trial (STAPLE-1) of the Aptus
endovascular repair system: results at 6 months and 1 year. J Vasc
Surg. 2009; 49:851-7.
Sidloff DA, Stather PW, Choke E, Bown MJ, Sayers RD. Type II
endoleak after endovascular aneurysm repair. Br J Surg. 2013;
100:1262-70.
Arenas Azofra E, Rey VM, Marcos FÁ, Al-Sibbai AZ, García FV, Pérez
MA. Results of Transarterial Embolization for Treating Type 2
Endoleaks: A Single-Center Experience. Ann Vasc Surg. 2019;
66:104-9.
Ierardi AM, Franchin M, Fontana F, Piffaretti G, Crippa M, Angileri
SA et al. The role of ethylene-vinyl alcohol copolymer in
association with other embolic agents for the percutaneous and
endovascular treatment of type Ia endoleak. Radiol Med. 2018;
123:638‐42.
Marcelin C, Le Bras Y, Petitpierre F, Midy D, Grenier N, Ducasse E,
et al. Embolization for persistent type IA endoleaks after chimney
endovascular aneurysm repair with Onyx®. Diagn Interv Imaging.

Vol. 71, No. 9, September 2021

Z. Rehman

11.

12.

13.

14.

15.

16.

17.

2017; 98:849‐55.
Ajalat M, Williams R, Wilson SE. The natural history of type 2
endoleaks after endovascular aneurysm repair justifies
conservative management. Vascular. 2018; 26:524‐30.
Bryce Y, Lam CK, Ganguli S, Schiro BJ, Cooper K, Cline M, et al.
Step-by-Step Approach to Management of Type II Endoleaks.
Tech Vasc Interv Radiol. 2018; 21:188‐95.
Dijkstra ML, Zeebregts CJ, Verhagen HJM, Teljink JAW, Power AH,
Bockler D, et al. Incidence, natural course, and outcome of type II
endoleaks in infrarenal endovascular aneurysm repair based on
the ENGAGE registry data. J Vasc Surg. 2020; 71:780‐9.
Candell L, Tucker LY, Goodney P, Walker J, Okuhn S, Hill B, et al.
Early and delayed rupture after endovascular abdominal aortic
aneurysm repair in a 10-year multicenter registry. J Vasc Surg.
2014; 60:1146-53.
Samura M, Morikage N, Mizoguchi T, Takeuchi Y, Nagase T, Harada
T, et al. Effectiveness of Embolization of Inferior Mesenteric Artery
to Prevent Type II Endoleak Following Endovascular Aneurysm
Repair: A Review of the Literature. Ann Vasc Dis. 2018; 11:259-64.
Manunga JM, Cragg A, Garberich R, Urbach JA, Skeik N, Alexander
J, et al. Preoperative Inferior Mesenteric Artery Embolization: A
Valid Method to Reduce the Rate of Type II Endoleak after EVAR?.
Ann Vasc Surg. 2017; 39:40-7.
Chaikof EL, Dalman RL, Eskandari MK, Jackson BM, Lee WA,
Mansour MA, et al. The Society for Vascular Surgery practice
guidelines on the care of patients with an abdominal aortic
aneurysm. J Vasc Surg. 2018; 67:2-77.

J Pak Med Assoc

2229
18.

19.

20.
21.

22.

23.

24.

25.

Kumar L, Cowled P, Boult M, Howell S, Fitridge R. Type II Endoleak
after Endovascular Aneurysm Repair: Natural History and
Treatment Outcomes. Ann Vasc Surg. 2017; 44:94‐102.
Galiñanes EL, Hernandez E, Krajcer Z. Preliminary results of
adjunctive use of endoanchors in the treatment of short neck and
pararenal abdominal aortic aneurysms. Catheter Cardiovasc
Interv. 2016; 87:E154-9.
Chen J, Stavropoulos SW. Management of Endoleaks. Semin
Intervent Radiol. 2015; 32:259-64.
Moulakakis KG, Klonaris C, Kakisis J, Antonopoulous CN, Lazaris A,
Sfyroeras GS, et al. Treatment of Type II Endoleak and Aneurysm
Expansion after EVAR. Ann Vasc Surg. 2017; 39:56‐66.
Abularrage CJ, Patel VI, Conrad MF, Schneider EB, Cambria RP,
Kwolek CJ, et al. Improved results using Onyx glue for the
treatment of persistent type 2 endoleak after endovascular
aneurysm repair. J Vasc Surg. 2012; 56:630-6.
Khaja MS, Park AW, Swee W, Evans AJ, Fritz Angle J, Turba UC, et
al. Treatment of type II endoleak using Onyx with long-term
imaging follow-up. Cardiovasc Intervent Radiol. 2014; 37:613-22.
Aoki A, Maruta K, Hosaka N, Omoto T, Masuda T, Gokan T.
Evaluation and Coil Embolization of the Aortic Side Branches for
Prevention of Type II Endoleak after Endovascular Repair of
Abdominal Aortic Aneurysm. Ann Vasc Dis. 2017; 10:351-8.
Wee I, Marjot T, Patel K, Bhrugubanda V, Choong AMTL.
Laparoscopic ligation of Type II endoleaks following endovascular
aneurysm repair: A systematic review. Vascular. 2018; 26:657-69.

